Taro Pharmaceutical Industries Overview

Taro Pharmaceutical Industries Other Income Expense Net

Other Income/Expense Net for TARO.

Quarterly Other Income/Expense

$17.44M

↑ 102.23% YoY

As of Mar 31, 2024

Annual Other Income/Expense (TTM)

$20.82M

↑ 87.31% YoY

Trailing 12 months ending Mar 31, 2024

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin